Table 3.
Adjusted effect of the five latent classes on health care use, diabetes-related complications from years 2013–2016, and 4-year all-cause mortality
Class 1b | Class 2 | Class 3 | Class 4 | Class 5 | Wald χ2 for class membership | |
---|---|---|---|---|---|---|
Class label | Younger patients with short T2DM duration and “relatively healthy” | Younger patients with short-to-moderate T2DM duration and moderate disease burden without end-organ complications | Younger females with short-to-moderate T2DM duration and high psychiatric and neurological disease burden | Older patients with moderate T2DM duration and moderate disease burden | Older patients with moderate-to-long T2DM duration, with depression, dementia, and high disease burden with end-organ complications | |
Total health care use from 2013 to 2016c | ||||||
Polyclinic visits | 1.00 | 1.53 (1.49–1.57)*** | 1.42 (1.33–1.52)*** | 1.53 (1.47–1.59)*** | 1.10 (1.06–1.14)*** | 2,820*** |
Private GP visits | 1.00 | 0.97 (0.92–1.02)* | 1.28 (1.12–1.45)*** | 0.91 (0.85–0.98)** | 0.73 (0.68–0.79)*** | 10,345*** |
SOC visits | 1.00 | 0.97 (0.94–1.00)* | 2.12 (1.97–2.29)*** | 1.17 (1.12–1.22)*** | 1.41 (1.35–1.47)*** | 2,214*** |
Emergency department visits | 1.00 | 1.02 (0.98–1.05)* | 3.31 (3.04–3.59)*** | 1.53 (1.46–1.61)*** | 2.47 (2.35–2.59)*** | 6,027*** |
Inpatient admissions | 1.00 | 1.05 (1.01–1.09)** | 2.70 (2.45–2.97)*** | 1.55 (1.46–1.63)*** | 2.82 (2.67–2.98)*** | 5,318*** |
4-Year risk of diabetes-related complicationsd | ||||||
Myocardial infarction | 1.00 | 2.74 (2.47–3.05)*** | 3.68 (3.01–4.50)*** | 3.11 (2.79–3.47)*** | 12.05(10.82–13.42)*** | 8,086*** |
End-stage renal disease requiring dialysis | 1.00 | 1.58 (1.33–1.87)*** | 1.51 (0.96–2.38)* | 1.95 (1.60–2.38)*** | 25.81 (21.75–30.63)*** | 41,417*** |
Stroke | 1.00 | 2.80 (2.45–3.20)*** | 7.45 (6.15–9.03)*** | 3.50 (3.06–4.02)*** | 19.37 (16.92–22.17)*** | 7,468*** |
LEA | 1.00 | 0.92 (0.77–1.10)* | 0.85 (0.48–1.49)* | 0.65 (0.52–0.81)*** | 12.94 (10.90–15.36)*** | 3,187*** |
4-Year all-cause mortalityd | 1.00 | 0.92 (0.83–1.01)* | 2.31 (1.94–2.74)*** | 1.20 (1.10–1.31)*** | 3.47 (3.17–3.80)*** | 15,960*** |
Data are IRR (95% CI) unless otherwise specified. Models were adjusted for age, sex, ethnicity, CHAS status, and duration of T2DM.
Reference group.
Negative binomial regression analyses were performed.
Cox proportional hazards regression analyses were performed. HRs reported with 95% CI.
P ≥ 0.05;
P < 0.05;
P < 0.001.